盘前跌近25%查看全文
北京时间2024年02月08日23时32分,方舟生物医药(ABIO.us)股票出现异动,股价急速拉升5.00%。截至发稿,该股报1.68美元/股,成交量1.5057万股,换手率0.10%,振幅2.19%。 最近的财报数据显示,该股实现营业... 网页链接
$方舟生物医药(ABIO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-22-010075 Act: 34 Size: 6 MB 网页链接
$方舟生物医药(ABIO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001567619-22-001853 Act: 34 Size: 66 KB 网页链接
$方舟生物医药(ABIO)$ 8-K Current report, item 5.02 Accession Number: 0001564590-21-060582 Act: 34 Size: 170 KB 网页链接
$方舟生物医药(ABIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-069960 Size: 11 KB 网页链接
$方舟生物医药(ABIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-069962 Size: 6 KB 网页链接
$方舟生物医药(ABIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-069963 Size: 10 KB 网页链接
$方舟生物医药(ABIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-069964 Size: 6 KB 网页链接
$方舟生物医药(ABIO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001564590-21-059167 Act: 34 Size: 467 KB 网页链接
$方舟生物医药(ABIO)$ 内部交易: 2021-11-22,S.V.P., General Counsel,Ozeroff Christopher David ,买入,50000普通股, $2.26
$方舟生物医药(ABIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-066497 Size: 8 KB 网页链接